lymphoma

Lori Solomon MONDAY, May 22, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has granted accelerated approval to Epkinly (epcoritamab-bysp) for relapsed or refractory diffuse large B-cell…

Hank Green, a popular YouTube personality known for his educational clips, took to the video platform Friday to share the news that he has been diagnosed with cancer.…

By BRETT MARTEL - AP Sports Writer METAIRIE, La. (AP) — Newly signed Saints tight end Foster Moreau, who is being treated for cancer, “absolutely” could participate in upcoming voluntary offseason…

<!-- Name:DistributionId Value:8808649 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

By TARA COPP - Associated Press WASHINGTON (AP) — The Air Force's review of cancers among its nuclear missile corps will include all personnel who worked on, guarded, supported or operated the nation’s…

Elana Gotkine MONDAY, Feb. 6, 2023 (HealthDay News) -- Female patients with diffuse large B-cell lymphoma (DLBCL) have worse outcomes when receiving rituximab plus cyclophosphamide, doxorubicin,…

By TARA COPP - Associated Press WASHINGTON (AP) — The top Air Force general in charge of the nation's air- and ground-launched nuclear missiles has requested an official investigation into the number of…

By TARA COPP - Associated Press WASHINGTON (AP) — The top Air Force general in charge of the nation's air- and ground-launched nuclear missiles has requested an official investigation into the number of…

Chemotherapy is a commonly used regimen for cancer treatment, but it is also a double-edged sword. While the drugs are highly effective at killing cancer cells, they are also notorious for killing healthy cells in the body. As such,…

Lori Solomon MONDAY, Jan. 23, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with…